Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hohage

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Praxis|November 26, 1996
[Polyneuropathy, diarrhea]F Koopmann, H Hohage, T Lorenz, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 21, 2003
Receptor assay based on surface plasmon resonance for the assessment of the complex formation activity of cyclosporin A and its metabolitesB Vollenbroeker, M Fobker, B Specht, et al.
Southern Medical Journal|January 7, 2000
Zinc protoporphyrin and percentage of hypochromic erythrocytes as markers of functional iron deficiency during therapy with erythropoietin in patients with advanced acquired immunodeficiency syndromeF K Matzkies, P Cullen, L Schaefer, et al.
Transplantation Proceedings|August 15, 2002
Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibitionBarbara Suwelack, M Kempkes-Koch, V Kobelt, et al.
Transplantation Proceedings|August 15, 2002
Cyclosporine does not influence serum cholesterol in kidney transplant recipientsFritz K Matzkies, W Keuthage, V Kobelt, et al.
Annals of Transplantation|May 31, 2002
Antihypertensive treatment in renal transplant patients--is there a role for ACE inhibitors?M Hausberg, M Kosch, H Hohage, et al.
Transplantation Proceedings|May 30, 2001
Cyclosporine A metabolite AM19 as a potential biomarker in urine for CSA nephropathyM Kempkes-Koch, M Fobker, M Erren, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Influence of purinoceptor antagonism on diadenosine pentaphosphate-induced hypotension in anesthetized ratsM Steinmetz, T van Le, P Hollah, et al.
Transplantation Proceedings|August 15, 2002
Influence of antihypertensive drugs on renal microcirculation and renal hemodynamics in cyclosporine A-treated ratsU Hillebrand, V Kobelt, M vOphoven, et al.
Transplantation Proceedings|April 26, 2005
Cyclosporine and tacrolimus: influence on cardiovascular risk factorsH Hohage, U Hillebrandt, U Welling, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Praxis|November 26, 1996
[Polyneuropathy, diarrhea]F Koopmann, H Hohage, T Lorenz, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 21, 2003
Receptor assay based on surface plasmon resonance for the assessment of the complex formation activity of cyclosporin A and its metabolitesB Vollenbroeker, M Fobker, B Specht, et al.
Southern Medical Journal|January 7, 2000
Zinc protoporphyrin and percentage of hypochromic erythrocytes as markers of functional iron deficiency during therapy with erythropoietin in patients with advanced acquired immunodeficiency syndromeF K Matzkies, P Cullen, L Schaefer, et al.
Transplantation Proceedings|August 15, 2002
Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibitionBarbara Suwelack, M Kempkes-Koch, V Kobelt, et al.
Transplantation Proceedings|August 15, 2002
Cyclosporine does not influence serum cholesterol in kidney transplant recipientsFritz K Matzkies, W Keuthage, V Kobelt, et al.
Annals of Transplantation|May 31, 2002
Antihypertensive treatment in renal transplant patients--is there a role for ACE inhibitors?M Hausberg, M Kosch, H Hohage, et al.
Transplantation Proceedings|May 30, 2001
Cyclosporine A metabolite AM19 as a potential biomarker in urine for CSA nephropathyM Kempkes-Koch, M Fobker, M Erren, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Influence of purinoceptor antagonism on diadenosine pentaphosphate-induced hypotension in anesthetized ratsM Steinmetz, T van Le, P Hollah, et al.
Transplantation Proceedings|August 15, 2002
Influence of antihypertensive drugs on renal microcirculation and renal hemodynamics in cyclosporine A-treated ratsU Hillebrand, V Kobelt, M vOphoven, et al.
Transplantation Proceedings|April 26, 2005
Cyclosporine and tacrolimus: influence on cardiovascular risk factorsH Hohage, U Hillebrandt, U Welling, et al.
Pageof 8